Mr. Gan · haixiao@sungolytest.com · +86 158 2169 5110 · +86 132 4819 8029Mr. Luo · jun.luo@sungoglobal.com · +86 177 5560 4650

SHW

Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis

Product code
SHW
Device name
Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis
Device class
Class 2
21 CFR
21 CFR 864.3755
Medical specialty
Pathology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A pathology software algorithm device analyzing digital images for cancer prognosis is a software intended to analyze scanned whole slide images (WSIs) from breast cancer specimens prepared from formalin fixed paraffin-embedded (FFPE) tissue and stained using Hematoxylin & Eosin (H&E) stains. The device provides prognostic risk estimates which are intended to assist physicians with prognostic risk-based decisions along with other clinicopathological factors. The device is not intended to determine a clinical diagnosis.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2026-05-04.

NumberDecision dateApplicantDevice nameSummary
K2541152026-05-04Artera, Inc.ArteraAI Breast—
Official FDA classification page: SHW
Classification and pathway per current FDA publications. Data from openFDA (CC0).